LL-37 is the only cathelicidin-derived anti-microbial peptide in humans and has been shown to stimulate proliferation, angiogenesis, cellular migration and inhibit apoptosis, in addition to serving as a chemoattractant for leukocytes. It is produced primarily by epithelial cells and leukocytes, and has recently been discovered to be over-expressed in breast, ovarian and lung cancers.
Based on these findings, we compared levels of LL-37 expression in benign and cancerous human prostate tissues. Results of this investigation demonstrated that LL-37 is increasingly over-expressed in primary prostate tumors in a grade dependent manner and in metastatic lesions. Since the physiological mechanisms of LL-37 are also key factors that become exaggerated in prostate cancer (PCa) and based on our preliminary findings regarding the over-expression of LL-37 in PCa in a grade dependent manner, we hypothesized that LL-37 may have a significant role in the neoplastic progression of PCa and serve as a potential therapeutic target.
We analogously examined the role of LL-37 in the neoplastic progression of PCa within an immunocompetent mouse PCa model, utilizing the murine orthologue of LL-37, Cathelicidin Related Anti-Microbial Peptide (CRAMP). Similar to the grade dependent over-expression of LL-37 in human PCa, we found CRAMP is increasingly over-expressed with advancing severity of primary prostate tumors and in metastatic lesions of the Transgenic Adenocarcinoma Mouse Prostate (TRAMP) model.
Modulation of CRAMP within TRAMP PCa cell lines significantly altered in vitro and in vivo pro-tumorigenic mechanisms. Our study demonstrated that CRAMP modulates the proliferation, invasiveness and matrix metalloproteinase (MMP) levels of these cells in a positive manner through the Erk1/2 and Akt pathways. In addition to replicating these findings, CRAMP knockdown in TRAMP-C1 cells also led to a significant in vivo reduction in tumor burdens, angiogenesis and the number of myeloidderived suppressor cells (MDSC) infiltrating into the tumor microenvironment.
The effects of CRAMP modulation on cellular proliferation, angiogenesis, invasion, MMP levels and the chemoattraction of MDSC in a mouse PCa model, support our hypothesis that LL-37 has a significant role in the neoplastic progression of PCa and may serve as an efficacious therapeutic target for PCa, and other cancers over-expressing the peptide.
Keywords: LL-37, CRAMP, prostate cancer, angiogenesis, MDSC
|Commitee:||Hel, Zdenek, Lopez, Richard D., Mountz, John D., Siegal, Gene P., Strong, Theresa V.|
|School:||The University of Alabama at Birmingham|
|School Location:||United States -- Alabama|
|Source:||DAI-B 72/08, Dissertation Abstracts International|
|Keywords:||Angiogenesis, Cathelicidin Related Anti-Microbial Peptide, Myeloid-derived suppressor cells, Prostate cancer|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be